Bank of Montreal Boosts Eli Lilly Stake 8.9% to $1.2B; Outperform Rating Stays
Bernstein reiterated an Outperform rating for Eli Lilly, while Bank of Montreal increased its stake by 8.9%, now holding 1.57 million shares valued at $1.2 billion. Eli Lilly shares rose 1.82% to $1,008.39 today on 2.0 million shares traded, with a market capitalization of $951.3 billion.
1. Bernstein Rating Reaffirmed
Bernstein analysts maintained an Outperform rating on Eli Lilly, signaling confidence in the company’s growth prospects and product pipeline. The reiteration underscores expectations for continued revenue contributions from key drugs and upcoming launch milestones.
2. Bank of Montreal Raises Position
Bank of Montreal increased its share count by 127,679 shares, boosting its total to 1,569,917 shares valued at $1.2 billion. This 8.9% stake increase reflects the bank’s bullish view on Eli Lilly’s long-term performance and market opportunities.
3. Other Institutional Movements
Brighton Jones LLC expanded its Eli Lilly holdings by 22% to 9,597 shares worth $7.4 million, while Revolve Wealth Partners LLC added 2.8% more shares to reach 1,471 shares. These adjustments indicate a broader trend of incremental accumulation among institutional investors.
4. Stock Performance and Market Metrics
Eli Lilly shares traded between $980.58 and $1,008.86 today, closing at $1,008.39 for a 1.82% gain on volume of 2.0 million shares. The company’s market capitalization stands at approximately $951.3 billion, highlighting its leadership in the pharmaceutical sector.